Hospital
Upmc Memorial
Upmc Memorial was paid $6.74M by Medicaid between Jan 2018 and Dec 2024, across 174 billing codes. Its largest line is 99284, emergency room visit (serious) — 30% of everything it billed.
33Billing provider infoUPMC MEMORIAL
YORK, PA 17408
YORK, PA 17408
33aNPI1063945707assigned 04/10/2017
33bProvider typeGeneral Acute Care Hospital
28Total paid$6.74M
24GClaims220,094
24DCodes billed174
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Pennsylvania
Rank by total paid#49 of 154
Median peer was paid$2.82M
This provider vs. median2.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 28 | $4K | |
| 2019 | 338 | $9K | |
| 2020 | 18,648 | $568K | |
| 2021 | 77,896 | $2.34M | |
| 2022 | 36,119 | $1.10M | |
| 2023 | 51,176 | $1.48M | |
| 2024incomplete | 35,889 | $1.23M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 30% | 19,883 | 19,250 | $2.02M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 10,250 | 9,992 | $750K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 5,347 | 5,184 | $723K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.5% | 2,011 | 1,959 | $373K |
| G0378 | Hospital observation service, per hour | 3.8% | 499 | 476 | $258K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.7% | 8,458 | 8,062 | $249K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 2.8% | 193 | 148 | $189K |
| 80053 | Comprehensive metabolic panel | 2.7% | 16,393 | 15,715 | $183K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.8% | 10,211 | 9,591 | $120K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.7% | 20,189 | 19,259 | $116K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.6% | 1,728 | 1,694 | $105K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.5% | 5,179 | 4,670 | $100K |
162 more codes
| 71046 | Radiologic examination, chest; 2 views | 1.3% | 5,955 | $89K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.3% | 1,286 | $86K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,132 | $63K |
| 84484 | <1% | 5,611 | $60K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 318 | $58K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 614 | $54K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 504 | $46K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,448 | $44K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 689 | $43K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 3,591 | $40K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,023 | $39K |
| 83605 | <1% | 4,347 | $34K | |
| 80061 | Lipid panel | <1% | 2,064 | $29K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,092 | $27K |
| 81001 | <1% | 9,094 | $26K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,952 | $26K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,091 | $25K |
| 87480 | <1% | 1,018 | $25K | |
| 87660 | <1% | 1,002 | $24K | |
| X0621 | <1% | 113 | $24K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 768 | $24K |
| 83690 | <1% | 4,886 | $23K | |
| 80050 | General health panel | <1% | 535 | $23K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 265 | $22K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,814 | $22K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 974 | $21K |
| 76830 | Ultrasound, transvaginal | <1% | 459 | $21K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,738 | $21K |
| 84703 | <1% | 1,987 | $20K | |
| 93971 | <1% | 307 | $20K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 319 | $19K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 799 | $18K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 295 | $17K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,258 | $17K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 233 | $17K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 345 | $16K |
| 83735 | <1% | 2,663 | $16K | |
| 93976 | <1% | 237 | $16K | |
| 80081 | <1% | 169 | $15K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 428 | $14K |
| 76801 | <1% | 315 | $14K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 323 | $13K |
| 83880 | <1% | 506 | $13K | |
| 87510 | <1% | 815 | $12K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 511 | $12K |
| 84702 | <1% | 619 | $11K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 4,272 | $10K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 72 | $10K |
| 88342 | <1% | 149 | $8K | |
| 76857 | <1% | 428 | $8K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 358 | $7K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 188 | $7K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 783 | $7K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 945 | $7K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 38 | $6K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 305 | $6K |
| 86803 | <1% | 304 | $6K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 261 | $6K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 223 | $6K |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 108 | $6K |
| 93970 | <1% | 65 | $5K | |
| 85027 | <1% | 733 | $4K | |
| 87040 | <1% | 260 | $4K | |
| 80076 | <1% | 458 | $4K | |
| 85610 | <1% | 1,207 | $4K | |
| 81025 | <1% | 859 | $4K | |
| 93017 | <1% | 107 | $4K | |
| 86850 | <1% | 418 | $3K | |
| 87186 | <1% | 422 | $3K | |
| 74018 | <1% | 257 | $3K | |
| 73610 | <1% | 180 | $3K | |
| 96376 | <1% | 354 | $3K | |
| 87077 | <1% | 416 | $3K | |
| 88312 | <1% | 72 | $3K | |
| 82570 | <1% | 393 | $3K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 13 | $3K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 102 | $3K |
| 86140 | <1% | 991 | $3K | |
| 85379 | <1% | 263 | $3K | |
| 87081 | <1% | 438 | $2K | |
| 84439 | <1% | 285 | $2K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 14 | $2K |
| 76536 | <1% | 51 | $2K | |
| 80143 | <1% | 156 | $2K | |
| 81003 | <1% | 644 | $2K | |
| 82728 | <1% | 169 | $2K | |
| 85730 | <1% | 375 | $2K | |
| 82043 | <1% | 237 | $2K | |
| 76642 | <1% | 42 | $2K | |
| 86901 | <1% | 440 | $2K | |
| 86900 | <1% | 443 | $2K | |
| 80179 | <1% | 126 | $2K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 44 | $2K |
| 73130 | <1% | 148 | $2K | |
| 73630 | <1% | 166 | $2K | |
| 83540 | <1% | 193 | $2K | |
| 81329 | <1% | 13 | $2K | |
| J3490 | Unclassified drugs | <1% | 1,952 | $1K |
| 72100 | <1% | 75 | $1K | |
| 77066 | Tomosynthesis, mammo | <1% | 12 | $1K |
| 86592 | <1% | 250 | $1K | |
| 82607 | <1% | 93 | $1K | |
| 90715 | <1% | 133 | $1K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 128 | $1K |
| 85652 | <1% | 367 | $1K | |
| 73030 | <1% | 75 | $1K | |
| 73564 | <1% | 50 | $938.37 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,941 | $930.75 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,579 | $885.18 |
| 77065 | Tomosynthesis, mammo | <1% | 12 | $863.69 |
| 84550 | <1% | 146 | $848.29 | |
| 82550 | <1% | 121 | $784.14 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 116 | $740.67 |
| 70486 | <1% | 13 | $728.51 | |
| 82565 | <1% | 103 | $689.44 | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 14 | $672.32 |
| 99000 | <1% | 109 | $654.00 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 32 | $612.61 |
| 83615 | <1% | 83 | $589.74 | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,038 | $544.72 |
| 83550 | <1% | 107 | $513.26 | |
| 87340 | <1% | 33 | $510.79 | |
| 82803 | <1% | 30 | $459.01 | |
| 84156 | <1% | 104 | $419.78 | |
| 82950 | <1% | 54 | $365.34 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,868 | $353.59 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 12 | $352.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 993 | $331.03 |
| 59025 | Fetal non-stress test | <1% | 34 | $288.54 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,716 | $278.89 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,219 | $214.64 |
| 87205 | <1% | 56 | $212.01 | |
| 86038 | <1% | 14 | $195.75 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,019 | $194.80 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,526 | $187.84 |
| 87070 | <1% | 27 | $163.57 | |
| 73110 | <1% | 14 | $160.45 | |
| 85014 | <1% | 50 | $132.06 | |
| 94060 | <1% | 14 | $125.58 | |
| 84100 | <1% | 45 | $124.27 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 473 | $112.81 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 13 | $86.30 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 579 | $81.46 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 404 | $65.61 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 199 | $52.39 |
| 84132 | <1% | 15 | $39.62 | |
| 82010 | <1% | 14 | $35.25 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 128 | $34.87 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 1,683 | $30.58 |
| V2632 | Posterior chamber intraocular lens | <1% | 91 | $26.13 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 743 | $25.54 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 140 | $25.20 |
| 36415 | Collection of venous blood by venipuncture | <1% | 57 | $6.71 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 92 | $3.30 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 0% | 13 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 98 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 36 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 13 | $0.00 |
| C1769 | Guide wire | 0% | 15 | $0.00 |
| A9573 | Injection, gadopiclenol, 1 ml | 0% | 25 | $0.00 |
| J1836 | Injection, metronidazole, 10 mg | 0% | 23 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMITSTIFER, GREGORY (CFO)
| Provider | Location | Paid |
|---|---|---|
| Upmc Pinnacle Hospitals | Harrisburg, PA | $26.92M |
| Upmc Carlisle | Carlisle, PA | $3.56M |
| Upmc Hanover | Hanover, PA | $2.92M |
| Upmc Lititz | Lititz, PA | $2.49M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.